PUBLIC COMPANY
save$AMPHAmphastar Pharmaceuticals, Inc.
$AMPH20.86-0.24%Rancho Cucamonga, CA, USupdated 9h ago
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
community read0 votes
🐶 often sniffed alongside
top 8- tagDrug Shortage6 co-mentions · 6 sources
- drugLIDOCAINE1 co-mentions · 1 sources
- drugAKTEN1 co-mentions · 1 sources
- drugatropine1 co-mentions · 1 sources
- druglidocaine SR1 co-mentions · 1 sources
- drugLaryng-O-Jet1 co-mentions · 1 sources
- drugLIDOCAINE HYDROCHLORIDE1 co-mentions · 1 sources
- drugSODIUM BICARBONATE1 co-mentions · 1 sources
pipeline
6
marketed
2
phase 3
0
catalysts ytd
9
approvals ytd
0
recalls ytd
0
Pipeline(6)
pipeline depth6 products
3Preclinical1Phase 22Marketed
Marketed
Baqsimi
Hypoglycemia
MarketedNEOSTIGMINE METHYLSULFATE
Acetylcholinesterase
Phase 2TERIPARATIDE
1 INDICATIONS AND USAGE Teriparatide injection is indicat…
Parathyroid hormone/parathyroid hormone-related peptide receptor
PreclinicalAMP-105
Head And Neck Squamous Cell Carcinoma (HNSC)
PreclinicalAMP-107
Diabetic Macular Edema
PreclinicalAMP-109
Colorectal Cancer
Upcoming
Recent(90d)
earnings (1)
Active trials
- phase3Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers
- phase3Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Mar 15, 26tax coverZhang Jack Y. · CEO & CHIEF SCIENTIFIC OFFICER9,784 sh
- Mar 15, 26tax coverZhang Jack Y. · CEO & CHIEF SCIENTIFIC OFFICER2,908 sh
- Mar 15, 26tax coverPETERS WILLIAM J · CFO, EVP & TREASURER1,973 sh
- Mar 15, 26tax coverZhou Rong · SENIOR EVP, PRODUCTION CENTER1,225 sh
- Mar 15, 26tax coverLiawatidewi Yakob · EVP CORP ADMIN CENTER1,033 sh
- Mar 10, 26tax coverZhang Jack Y. · CEO & CHIEF SCIENTIFIC OFFICER14,785 sh
🐶 Hiring Signal
next earnings Nov 5, 2026
News
- FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid OverdoseThe U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone hydrochloride nasal spray for the emergen…fda_press · 2mo ago
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that